ACCORD HEALTHCARE LIMITED
Location
Founded
2004-04-13
Risk Signals
336 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Medicinal Chemicals and Botanical Products, Pharmaceutical Preparations, Drugs, Drug Proprietaries, and Druggists' Sundries), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about ACCORD HEALTHCARE LIMITED
Live alerts from global media, monitored by Business Radar
2025-02-01 (prnewswire.co.uk)
Accord Healthcare launches Disulfiram in the United Kingdom, indicated as a supportive agent in the treatment of alcoholism
/PRNewswire/ -- Accord Healthcare UK Ltd announces that following launch to wholesalers in Dec 2024, the alcohol deterrent compound Disulfiram (the active...
Read more
2023-10-11 (prnewswire.co.uk)
Accord Healthcare launches Accord Animal Health
/PRNewswire/ -- Accord Healthcare, one of the fastest-growing pharmaceutical companies in Europe, committed to providing high-quality medicines at the point of...
Read more
2023-06-23 (pharmaphorum.com)
Accord launches app to help cancer patients manage symptoms
Accord Healthcare has introduced a new app in the UK designed to help people undergoing treatment for cancer maintain their physical and mental wellbeing.The Unify Health app helps patients understand their illness, track symptoms and treatment progress, receive tips on health habits and importantly
Read more
2020-10-02 (centerforbiosimilars.com)
Accord Launches 2 Biosimilars in the UK, Expands Partnership With Henlius
Accord brought 2 biosimilars referencing blockbuster oncology products to the United Kingdom and amended its agreement with Shanghai Henlius Biotech.
Read more
2020-09-25 (pharmatimes.com)
Accord Healthcare launches Herceptin biosimilar in the UK
Accord Healthcare has launched Zercepac (trastuzumab), a biosimilar of Roche’s Herceptin, in the UK after winning approval from the European Commission in July.
Read more
2020-09-24 (prnewswire.co.uk)
Accord Healthcare Launches Zercepac®▼ (trastuzumab) biosimilar in the UK
/PRNewswire/ -- Accord Healthcare (Accord) today announced the launch of Zercepac® (trastuzumab) as a biosimilar of the reference product Herceptin®, in the...
Read more